Financials
| Div Yield |
3.1% |
7.8% |
| Div Cover |
2.54 |
n/a |
| Op Mrgn |
70.0% |
n/a |
| ROCE |
69.0% |
|
| P/E |
62.99 |
16.50 |
| PEG |
2.93 |
2.81 |
| Pr/Revenue |
11.17 |
n/a |
| Pr/Book |
3.96 |
|
| Revenue |
6.1% |
n/a |
| PBT |
25.5% |
n/a |
| EPS |
8.0% |
243.7% |
| DPS |
14.6% |
|
| 1 week |
10,609.08 |
-332.82 |
-3.14% |
| 1 month |
9,967.35 |
+308.91 |
+3.10% |
| 3 months |
10,171.76 |
+104.50 |
+1.03% |
| 6 months |
9,756.14 |
+520.12 |
+5.33% |
| 1 year |
8,463.46 |
+1,812.80 |
+21.42% |
| BKG | 28-Apr-26 |
Buy |
Robert C G Perrins |
3,245.14p | 7,000 |
£227,160.02 |
| GSK | 27-Apr-26 |
Transfer From |
Julie Brown |
0.000p | 0 |
£0.00 |
| RR. | 27-Apr-26 |
Transfer From |
Tufan Erginbilgic |
0.000p | 135 |
£0.00 |
| DCC |
5,720.00p |
+6.3% |
| SWR |
3,001.00p |
+3.8% |
| FLTR |
8,136.00p |
+1.5% |
| CRDA |
2,875.00p |
+1.3% |
| GLEN |
557.10p |
+1.1% |
| PSH |
4,202.00p |
+1.1% |
| RMV |
438.00p |
+0.9% |
| BAB |
1,106.00p |
+0.9% |
| ANTO |
3,517.00p |
+0.8% |
| SMT |
1,396.50p |
+0.8% |
| STJ |
1,183.50p |
-5.5% |
| NXT |
12,995.00p |
-2.6% |
| GSK |
1,976.00p |
-2.6% |
| III |
2,526.00p |
-2.5% |
| HLN |
342.10p |
-2.5% |
| MRO |
477.20p |
-2.3% |
| BA. |
2,006.00p |
-2.0% |
| BRBY |
1,149.80p |
-1.8% |
| RR. |
1,117.60p |
-1.5% |
| MTLN |
34.19 |
-1.5% |
Top of Page
You are here:
research